Microbot Medical (MBOT) Stock Price, News & Analysis

Company Overview

Microbot Medical, Inc. (NASDAQ: MBOT) is a clinical-stage medical device company focused on developing innovative micro-robotic technologies to transform minimally invasive procedures. The company’s platforms harness magnetic navigation, microfabrication and advanced control systems to deliver precision tools for interventional therapies. By combining robotics with catheter-based approaches, Microbot Medical strives to improve procedural efficiency and patient outcomes in a range of cardiovascular and peripheral vascular indications.

The company’s lead product candidates include the Hydra platform, designed to navigate and clear vascular obstructions in coronary and peripheral arteries. Hydra micro-robots are engineered to selectively remove plaque, thrombus and calcium build-up, offering a complementary approach to traditional balloon angioplasty and stenting. In preclinical studies, the platform has demonstrated the ability to access complex vessel anatomies and reduce the risk of downstream embolization, potentially enabling physicians to treat challenging lesions with greater confidence.

Founded in 2010, Microbot Medical is headquartered in New York with research and development operations in Israel. Over the past decade, the company has built a robust intellectual property portfolio, securing patents in key global markets. Strategic collaborations with leading academic medical centers and partnerships in Europe and Asia support ongoing clinical programs and regulatory filings. These efforts position Microbot Medical to advance toward first-in-human studies and future commercial adoption across developed and emerging healthcare markets.

Microbot Medical’s leadership team is led by Chairman and CEO Dr. Itai Yabe, who brings extensive experience in medical device innovation and corporate development. The executive suite includes Chief Medical Officer Dr. Eitan Ornoy and Chief Technology Officer Dr. Zvi Cohen, each contributing deep expertise in interventional cardiology and micro-robotic engineering. Together, they guide the company’s mission to deliver next-generation tools that address unmet needs in minimally invasive therapy.

Key Stats

• Today's Range: $2.51 to $2.72
• 50-Day Range: $2.34 to $2.83
• 52-Week Range: $0.82 to $3.38
• Volume: 1.34 million shs
• Average Volume: 1.80 million shs
• Market Capitalization: $91.67 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $9.00
• Consensus Rating: Buy

Microbot Medical Stock Analysis - MarketRank™

Microbot Medical scored higher than 43% of companies evaluated by MarketBeat, and ranked 679th out of 939 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Microbot Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Microbot Medical has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Microbot Medical are expected to grow in the coming year, from ($0.71) to ($0.52) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Microbot Medical is -3.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Microbot Medical is -3.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Microbot Medical has a P/B Ratio of 14.82. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

22.83% of the float of Microbot Medical has been sold short.

Short Interest Ratio / Days to Cover

Microbot Medical has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Microbot Medical has recently decreased by 1.86%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Microbot Medical does not currently pay a dividend.

Dividend Growth

Microbot Medical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

22.83% of the float of Microbot Medical has been sold short.

Short Interest Ratio / Days to Cover

Microbot Medical has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Microbot Medical has recently decreased by 1.86%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.90

News Sentiment

Microbot Medical has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.01 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for Microbot Medical this week, compared to 1 article on an average week.

Search Interest

Only 12 people have searched for MBOT on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

Only 3 people have added Microbot Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Microbot Medical insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 4.74% of the stock of Microbot Medical is held by insiders.

Percentage Held by Institutions

Only 16.30% of the stock of Microbot Medical is held by institutions.

MBOT Stock Analysis - Frequently Asked Questions

How have MBOT shares performed this year?

Microbot Medical's stock was trading at $1.12 on January 1st, 2025. Since then, MBOT stock has increased by 125.0% and is now trading at $2.52.

How were Microbot Medical's earnings last quarter?

Microbot Medical Inc. (NASDAQ:MBOT) posted its earnings results on Wednesday, May, 21st. The biotechnology company reported ($0.08) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.07.

When did Microbot Medical's stock split?

Shares of Microbot Medical reverse split before market open on Monday, May 9th 2016.The 1-12 reverse split was announced on Friday, May 6th 2016. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 6th 2016. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Who are Microbot Medical's major shareholders?

Top institutional shareholders of Microbot Medical include U.S. Capital Wealth Advisors LLC (0.03%).
View institutional ownership trends.

How do I buy shares of Microbot Medical?

Shares of MBOT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Microbot Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Microbot Medical investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), TransEnterix (TRXDW), Pfizer (PFE), Plug Power (PLUG) and Novavax (NVAX).

Company Calendar

• Last Earnings: 5/21/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/13/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:MBOT
• CIK: 883975
• Web: www.microbotmedical.com
• Phone: (781) 875-3605
• Fax: 781-556-5347
• Employees: 20
• Year Founded: 2010

Price Target and Rating

• Average Price Target for Microbot Medical: $9.00
• High Price Target: $9.00
• Low Price Target: $9.00
• Potential Upside/Downside: +257.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 1 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.44 million
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -110.27%
• Return on Assets: -94.20%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 16.19
• Quick Ratio: 16.19

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.17 per share
• Price / Book: 14.79

Miscellaneous

• Outstanding Shares: 36,378,000
• Free Float: 34,654,000
• Market Cap: $91.49 million
• Optionable: Optionable
• Beta: 1.13